NEW RESEARCH: Updated Executive Informational Overview for AtheroNova Inc. (AHRO)

Posted by Laura Swartz

January 22, 2014 at 12:32 PM

We released a new report today--an Updated Executive Informational Overview--on AtheroNova Inc. (AHRO-OTC). AtheroNova is a clinical-stage biotechnology company focused on the research and development of bile acid therapeutic compounds to safely dissolve or regress atherosclerotic plaque and improve patients’ lipid profiles. Atherosclerotic plaque, a buildup of fat, cholesterol, and other substances in the walls of arteries, is the main underlying cause of cardiovascular disease, including heart attacks, strokes, and peripheral artery disease (PAD).

The Company’s most advanced candidate, AHRO-001, works to reduce the incidence and severity of plaque by employing a bile acid to reduce the volume of or stabilize existing plaque deposits and prevent new deposits from forming. The compound also shows significant preclinical lipid panel improvement and has beneficial effects on glucose levels involving multiple mechanisms of action.

Read More

Topics: AtheroNova

New Video Available: Regenerative Medicine Panel at OneMedForum SF 2014

Posted by Laura Swartz

January 21, 2014 at 10:06 AM

If you missed the "Extending Life and Limb" workshop on regenerative medicine held last week at the OneMedForum conference in San Francisco, you can watch the full panel discussion on YouTube at the link below.

Read More

Topics: Crystal Research Associates, OneMedForum

Regenerative Medicine "Extending Life and Limb" Workshop

Posted by Laura Swartz

January 13, 2014 at 4:48 PM

If you are in San Francisco today for the JP Morgan Healthcare Conference, the Biotech Showcase, or the 7th annual OneMedForum, we welcome you to stop by the Westin San Francisco on Market Street to visit our booth and hear Crystal Research CEO Jeffrey Kraws speak on regenerative medicine.

Read More

Topics: Crystal Research Associates, OneMedForum

We have an app and a brand new website!

Posted by Laura Swartz

January 13, 2014 at 12:00 PM

Crystal Research Associates is pleased to announce today that we have officially launched our mobile app and our new website. Take a look around at some of the changes...it is now easier than ever to sign up for research notifications and even start a discussion with us about your business's strategic needs. We have also recently expanded our line of products and services, which is now reflected throughout the site.

Read More

Topics: Crystal Research Associates, IR App

NEW Quarterly Update Available for CardioComm Solutions (EKG-TSX.V)

Posted by Laura Swartz

January 2, 2014 at 10:38 AM

Happy New Year!

Read More

Topics: CardioComm Solutions

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic